Structural studies of the hypothalamus and its nuclei in mood disorders

Psychiatry Research - Neuroimaging

Volumn 201, Issue 1, 2012, Pages 1-9

  Schindler, Stephanie ^a   Geyer, Stefan ^b   Strauß, Maria ^a   Anwander, Alfred ^b   Hegerl, Ulrich ^a   Turner, Robert ^b   Schönknecht, Peter ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

Author keywords

Bipolar disorder; Depression; MRI; Volumetry

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; OXYTOCIN;

ANTERIOR COMMISSURE; BRAIN AQUEDUCT; BRAIN SIZE; BRAIN THIRD VENTRICLE; HUMAN; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; IMMUNOREACTIVITY; IN VIVO STUDY; MAMMILLARY BODY; MOOD DISORDER; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SUPRAOPTIC NUCLEUS;

HUMANS; HYPOTHALAMUS; MAGNETIC RESONANCE IMAGING; MOOD DISORDERS; NEURONS; ORGAN SIZE;

EID: 84857447451     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2011.06.005     Document Type: Review

References (101)

1. Amunts K., Kedo O., Kindler M., Pieperhoff P., Mohlberg H., Shah N.J., Habel U., Schneider F., Zilles K. Cytoarchitectonic mapping of the human amygdala, hippocampal region and entorhinal cortex: Intersubject variability and probability maps. Anatomy and Embryology 2005, 210. 3443-352.
2. Anwander A., Tittgemeyer M., von Cramon D.Y., Friederici A.D., Knösche T.R. Connectivity-based parcellation of Broca's area. Cerebral Cortex 2007, 17:816-825.
3. Ashburner J., Friston K.J. Voxel-based morphometry-the methods. NeuroImage 2000, 11:805-821.
4. Axelson D.A., Doraiswamy P.M., Boyko O.B., Escalona P.R., McDonald W.M., Ritchie J.C., Patterson L.J., Ellinwood E.H., Nemeroff C.B., Krishnan K.R.R. In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients. Psychiatry Research 1992, 44:63-70.
5. Bao A.-M., Hestiantoro A., Van Someren E.J.W., Swaab D.F., Zhou J.-N. Colocalization of corticotropin-releasing hormone and oestrogen receptor-α in the paraventricular nucleus of the hypothalamus in mood disorders. Brain 2005, 128:1301-1313.
6. Bao A.-M., Meynen G., Swaab D.F. The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Research Reviews 2008, 57:531-553.
7. Baumann B., Bogerts B. Neuroanatomical studies on bipolar disorder. The British Journal of Psychiatry 2001, 178(suppl. 41):s142-s147.
8. Bazin P.L., Pham D.L. Homeomorphic brain image segmentation with topological and statistical atlases. Medical Image Analysis 2011, 12:616-625.
9. Bernstein H.-G., Stanarius A., Baumann B., Henning H., Krell D., Danos P., Falkai P., Bogerts B. Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 1998, 83:867-875.
10. Bernstein H.-G., Heinemann A., Krell D., Mawrin C., Bielau H., Danos P., Diekmann S., Keilhoff G., Bogerts B., Baumann B. Further immunohistochemical evidence for impaired NO signaling in the hypothalamus of depressed patients. Annals of the New York Academy of Sciences 2002, 973:91-93.
11. Beyer J.L., Krishnan K.R.R. Volumetric brain imaging findings in mood disorders. Bipolar Disorders 2002, 4:89-104.
12. Bhadoria R., Watson D., Danson P., Ferrier I.N., McAllister V., Moore P.B. Enlargement of the third ventricle in affective disorders. Indian Journal of Psychiatry 2003, 45:147-150.
13. Bielau H., Trübner K., Krell D., Agelink M.W., Bernstein H.-G., Strauch R., Mawrin C., Danos P., Gerhard L., Bogerts B., Baumann B. Volume deficits of subcortical nuclei in mood disorders. European Archives of Psychiatry and Clinical Neuroscience 2005, 255:401-412.
14. Bogerts B. Gibt es geschlechtsspezifische neuropathologische Korrelate der Depression. Journal für Neurologie, Neurochirurgie und Psychiatrie 2010, 11:29-35.
15. Bowley M.P., Drevets W.C., Öngür D., Price J.L. Low glial numbers in the amygdala in major depressive disorder. Biological Psychiatry 2002, 52:404-412.
16. Brockhaus H. Beitrag zur normalen Anatomie des Hypothalamus und der Zona incerta beim Menschen. Journal für Psychologie und Neurologie 1942, 51:96-196.
17. Buchsbaum M.S., Schönknecht P., Torosjan Y., Newmark R., Chu K.-W., Mitelman S., Brickman A.M., Shihabuddin L., Hazndar M.M., Hazlett E.A., Ahmed S., Tang C. Diffusion tensor imaging of frontal lobe white matter tracts in schizophrenia. Annals of General Psychiatry 2006, 5. (Electronic publication ahead of print, Nov 28).
18. Callen D.J.A., Black S.E., Gao F., Caldwell C.B., Szalai J.P. Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD. Neurology 2001, 57:1669-1674.
19. Chen H.H., Nicoletti M., Sanches M., Hatch J.P., Sassi R.B., Axelson D.A., Brambilla P., Keshavan M.S., Ryan N., Birmaher B., Soares J.C. Normal pituitary volumes in children and adolescents with bipolar disorder: a magnetic resonance imaging study. Depression and Anxiety 2004, 20:182-186.
20. Cousins D.A., Butts K., Young A.H. The role of dopamine in bipolar disorder. Bipolar Disorders 2009, 11:787-806.
21. Cousins D.A., Moore P.B., Watson S., Harrison L., Ferrier I.N., Young A.H., Lloyd A.J. Pituitary volume and third ventricle width in euthymic patients with bipolar disorder. Psychoneuroendocrinology 2010, 35:1074-1081.
22. Daban C., Viety E., Mackin P., Young A.H. Hypothalamic-pituitary-adrenal axis and bipolar disorder. The Psychiatric Clinics of North America 2005, 28:469-480.
23. Dinan T.G., Lavell E., Scott L.V., Newell-Price J., Medbak S., Grossman A.B. Desmopressin normalizes the blunted adrenocorticotropin response to corticotropin-releasing hormone in melancholic depression: evidence of enhanced vasopressinergic responsivity. Journal of Clinical Endocrinology and Metabolism 1999, 84:2238-2240.
24. Dorph-Petersen K.A., Nyengaard J.R., Gundersen H.J. Tissue shrinkage and unbiased stereological estimation of particle number and size. Journal of Microscopy 2001, 204:232-246.
25. Draganski B., Geisler P., Hajak G., Schuierer G., Bogdahn U., Winkler J., May A. Hypothalamic gray matter changes in narcoleptic patients. Nature Medicine 2002, 8:1186-1187.
26. Drevets W.C. Neuroimaging studies of mood disorders. Biological Psychiatry 2000, 48:813-829.
27. Drevets W.C., Price J.L., Furey M.L. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Structure & Function 2008, 213:93-118.
28. Dupont R.M., Jernigan T.L., Heindel W., Butters N., Shafer K., Wilson T., Hesslink J., Gillin J.C. Magnetic resonance imaging and mood disorders. Archives of General Psychiatry 1995, 52:747-755.
29. Eker C., Ovali G.Y., Ozan E., Eker O.D., Kitis O., Coburn K., Gonul A.S. No pituitary gland volume change in medication-free depressed patients. Progress in Neuropsychopharmacology & Biological Psychiatry 2008, 32:1628-1632.
30. England M.A., Wakely J. Color atlas of the brain and spinal cord. An introduction to normal neuroanatomy 2006, Mosby, Philadelphia. 2nd ed.
31. Fuchs E., Czéh B., Flügge G. Examining novel concepts of the pathophysiology of depression in the chronic psychosocial stress paradigm in tree shrews. Behavioural Pharmacology 2004, 15:315-325.
32. Goldstein J.M., Seidman L.J., Horton N.J., Makris N., Kennedy D.N., Caviness V.S.J., Faraone S.V., Tsuang M.T. Normal sexual dimorphism of the adult human brain assessed by in vivo magnetic resonance imaging. Cerebral Cortex 2001, 11. 490-407.
33. Goldstein J.M., Seidman L.J., Makris N., Ahem T., O'Brien L.M., Caviness V.S.J., Kennedy D.N., Faraone S.V., Tsuang M.T. Hypothalamic abnormalities in schizophrenia: sex effects and genetic vulnerability. Biological Psychiatry 2007, 61:935-945.
34. Hadjipavlou G., Dunckley P., Behrens T.E., Tracey I. Determining anatomical connectivities between cortical and brainstem pain processing regions in humans: a diffusion tensor imaging study in healthy controls. Pain 2006, 123:169-178.
35. Hauser P., Matochik J., Altshuler L.L., Denicoff K.D., Conrad A., Li X., Post R.M. MRI-based measurements of temporal lobe and ventricular structures in patients with bipolar I and bipolar II disorders. Journal of Affective Disorders 2000, 60:25-32.
36. Helms G., Draganski B., Frackowiak R., Ashburner J., Weiskopf N. Improved segmentation of deep brain grey matter structures using magnetization transfer (MT) parameter maps. NeuroImage 2009, 47:194-198.
37. Hendrie C.A., Pickles A.R. Depression as an evolutionary adaptation: anatomical organisation around the third ventricle. Medical Hypotheses 2010, 74:735-740.
38. Hofman M.A. Suprachiasmatic nucleus of the human brain: an immunocytochemical and morphometric analysis. The Anatomical Record 1996, 224:552-562.
39. Hofman M.A., Swaab D.F. The human hypothalamus: comparative morphometry and photoperiodic influences. Progress in Brain Research 1992, 93:133-147.
40. Hofman M.A., Swaab D.F. Diurnal and seasonal rhythms of neuronal activity in the suprachiasmatic nucleus of humans. Journal of Biological Rhythms 1993, 8:283-295.
41. Hofman M.A., Purba J.S., Swaab D.F. Annual variations in the vasopressin neuron population of the human suprachiasmatic nucleus. Neuroscience 1993, 53:1103-1112.
42. Horga G., Bernacer J., Dusi N., Entis J., Chu K., Hazlett E.A., Mehmet Haznedar M., Kemether E., Byne W., Buchsbaum M.S. Correlations between ventricular enlargement and gray and whitematter volumes of cortex, thalamus, striatum, and internal capsule in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 2011, 261(7):467-476.
43. Hulshoff Pol H.E., Cohen-Kettenis P.T., Van Haren N.E.M., Peper J.S., Brans R.G.H., Cahn W., Schnack H.G., Gooren L.J.G., Kahn R.S. Changing your sex changes your brain: influences of testosterone and estrogen on adult human brain structure. European Journal of Endocrinology 2006, 155:s107-s114.
44. Jernigan T.L., Trauner D.A., Hesselink J.R., Trallal P.A. Maturation of human cerebrum observed in vivo during adolescence. Brain 1991, 114:2037-2049.
45. Johansen-Berg H., Behrens T.E.J., Robson M.D., Drobnjak I., Rushworth M.F.S., Brady J.M., Smith S.M., Higham D.J., Matthews P.M. Changes in connectivity profiles define functionally distinct regions in human medial frontal cortex. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:13335-13340.
46. Kempton M.J., Geddes J.R., Ettinger U., Williams S.C., Grasby P.M. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Archives of General Psychiatry 2008, 65:1017-1032.
47. Konarski J.Z., McIntyre R.S., Kennedy S.H., Rafi-Tari S., Soczynska J.K., Ketter T.A. Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder. Bipolar Disorders 2008, 10:1-37.
48. Koolschijn P.C.M.P., van Haren N.E.M., Hulshoff Pol H.E. Hypothalamus volume in twin pairs discordant for schizophrenia. European Neuropsychopharmacology 2008, 18:312-315.
49. Koutcherov Y., Mai J.K., Ashwell K.W., Paxinos G. Organization of the human paraventricular hypothalamic nucleus. The Journal of Comparative Neurology 2000, 423:299-318.
50. Krishnan K.R.R., Doraiswamy P.M., Lurie S.N., Figiel G.S., Husain M.M., Boyko O.B., Ellinwood E.H., Nemeroff C.B. Pituitary size in depression. Journal of Clinical Endocrinology and Metabolism 1991, 72:256-259.
51. Lancaster J.L., Woldorff M.G., Parsons L.M., Liotti M., Freitas C.S., Rainey L., Kochunov P.V., Nickerson D., Mikiten S.A., Fox P.T. Automated Talairach atlas labels for functional brain mapping. Human Brain Mapping 2000, 10:120-131. Program retrieved 2010 July 16, from. http://www.talairach.org/.
52. Lemaire J.-J., Frew A.-K., McArthur D., Gorgulho A.A., Alger J.R., Salomon N., Chen C., Behnke E.J., De Salles A.A.F. White matter connectivity of human hypothalamus. Brain Research 2011, 34:554.
53. MacMaster F.P., Leslie R., Rosenberg D.R., Kusumakar V. Pituitary gland volume in adolescent and young adult bipolar and unipolar depression. Bipolar Disorders 2008, 10:101-104.
54. Mai J.K., Kedziora O., Teckhaus L., Sofroniew M.V. Evidence for subdivisions in the human suprachiasmatic nucleus. The Journal of Comparative Neurology 1991, 305:508-525.
55. Malhi G.S., Lagopulos J., Sachdev P., Mitchell P.B., Ivanovski B., Parker G.B. Cognitive generation of affect in hypomania: an fMRI study. Bipolar Disorders 2004, 6:271-285.
56. Malhi G.S., Lagopulos J., Ward P.B., Kumari V., Mitchell P.B., Parker G.B., Ivanovski B., Sachdev P. Cognitive generation of affect in bipolar depression: an fMRI study. European Journal of Neuroscience 2004, 19:741-745.
57. Manaye K.F., Lei D.L., Tizabi Y., Dávila-García M.I., Mouton P.R., Kelly P.H. Selective neuron loss in the paraventricular nucleus of hypothalamus in patients suffering from major depression and bipolar disorder. Journal of Neuropathology and Experimental Neurology 2005, 64:224-229.
58. Manji H.K., Moore G.J., Chen G. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biological Psychiatry 2000, 48:740-754.
59. Manji H.K., Quiroz J.A., Sporn J., Payne J.L., Denicoff K., Grey N.A., Zarate C.A., Charney D.S. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biological Psychiatry 2003, 53:707-742.
60. Mayberg H.S., Brannan S.K., Tekell J.L., Silva J.A., Mahurin R.K., McGinnis S., Jerabek P.A. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biological Psychiatry 2000, 48:830-843.
61. McDonald C., Zanelli J., Rabe-Hesketh S., Ellison-Wright I., Sham P., Kalidindi S., Murray R.M., Kennedy N. Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder. Biological Psychiatry 2004, 56:411-417.
62. Meynen G., Unmehopa U.A., van Heerikhuize J.J., Hofman M.A., Swaab D.F., Hoogendijk W.J. Increased arginine vasopressin mRNA expression in the human hypothalamus in depression: a preliminary report. Biological Psychiatry 2006, 60:892-895.
63. Mondelli V., Dazzan P., Gabilondo A., Tournikioti K., Muriel W., Marshall N., Schulze K.K., Murray R.M., McDonald C., Pariante C.M. Pituitary volume in unaffected relatives of patients with schizophrenia and bipolar disorder. Psychoneuroendocrinology 2008, 33:1004-1012.
64. Moore R.Y. The fourth C.U. Ariëns Kappers lecture. The organization of the human circadian timing system. Progress in Brain Research 1992, 93:99-115.
65. Moore G.J., Bebchuk J.M., Wilds I.B., Chen G., Manji H.K. Lithium-induced increase in human brain grey matter. Lancet 2000, 356:1241-1242.
66. Nieuwenhuys R., Voogd J., van Huijzen C. Diencephalon: Hypothalamus. The Human Central Nervous System: A Synopsis and Atlas 2008, 289-336. Springer, Berlin. 4th ed.
67. Nieuwenhuys R., Voogd J., van Huijzen C. The human central nervous system: a synopsis and atlas 2008, Springer, Berlin. 4th ed.
68. Pearlson G.D., Barta P.E., Powers R.E., Menon R.R., Richards S.S., Aylward E.H., Federman E.B., Chase G.A., Petty R.G., Tien A.Y. Ziskind-Somerfeld Research Award 1996. Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder. Biological Psychiatry 1997, 41:1-14.
69. Pinilla, B. P., 2009. Auswirkungen der unipolar depressiven Störung auf strukturelle Gehirnveränderungen in der Voxel-based-NMR-Morphometry und auf "hippocampusspezifische" kognitive Leistungen. Charité Berlin: Inaugural-Dissertation.
70. Piquet O., Petersén A., Yin Ka Lam B., Gabery S., Murphy K., Hodges J.R., Halliday G.M. Eating and hypothalamus changes in behavioral-variant frontotemporal dementia. Annals of Neurology 2011, 69:312-319.
71. Price J.L., Drevets W.C. Neurocircuitry of mood disorders. Neuropsychopharmacology 2010, 35:192-216.
72. Purba J.S., Hoogendijk W.J., Hofman M.A., Swaab D.F. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Archives of General Psychiatry 1996, 53:137-143.
73. Raadsheer F.C., Hoogendijk W.J., Stam F.C., Tilders F.J., Swaab D.F. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 1994, 60:436-444.
74. Raadsheer F.C., van Heerikhuize J.J., Lucassen P.J., Hoogendijk W.J., Tilders F.J., Swaab D.F. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. The American Journal of Psychiatry 1995, 152:1372-1376.
75. Rajeevan, N., Papademetris, X., no year. MNI to Talairach coordinates converter. Retrieved 2010 Juli 16, from http://www.bioimagesuite.org/Mni2Tal.
76. Ranson S.W., Magoun H.W. The hypothalamus. Ergebnisse der Physiologie, biologischen Chemie und experimentellen Pharmakologie 1939, 41:56-163.
77. Rubin R.T., Phillips J.J., McCracken J.T., Sadow T.F. Adrenal gland volume in major depression: relationship to basal and stimulated pituitary-adrenal cortical axis function. Biological Psychiatry 1996, 40:89-97.
78. Sassi R.B., Nicoletti M., Brambilla P., Harenski K., Mallinger A.G., Frank E., Kuper D.J., Keshavan M.S., Soares J.C. Decreased pituitary volume in patients with bipolar disorder. Biological Psychiatry 2001, 50:271-280.
79. Schwartz P.J., Loe J.A., Bash C.N., Bove K., Turner E.H., Frank J.A., Wehr T.A., Rosenthal N.E. Seasonality and pituitary volume. Psychiatry Research: Neuroimaging 1997, 74:151-157.
80. Scott L.V., Dinan T.G. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression. Life Sciences 1998, 62:1985-1998.
81. Sedrak M., Gorgulho A., De Salles A.F., Frew A., Behnke E., Ishida W., Klochkov T., Malkasian D. The role of modern imaging modalities on deep brain stimulation targeting for mental illness. Acta Neurochirurgica. Supplement 2008, 101:3-7.
82. Shear P.K., Sullivan E.V., Lane B., Pfefferbaum A. Mammillary body and cerebellar shrinkage in chronic alcoholics with and without amnesia. Alcoholism, Clinical and Experimental Research 1996, 20:1489-1495.
83. Soares J.C., Mann J.J. The anatomy of mood disorders-review of structural neuroimaging studies. Biological Psychiatry 1997, 41:86-106.
84. Solano-Castiella E., Anwander A., Lohmann G., Weiss M., Docherty C., Geyer S., Reimer E., Friederici A.D., Turner R. Diffusion tensor imaging segments the human amygdala in vivo. NeuroImage 2010, 49:2958-2965.
85. Sørensen P.S., Gjerris A., Hammer M. Cerebrospinal fluid vasopressin in neurological and psychiatric disorders. Journal of Neurology, Neurosurgery, and Pychiatry 1985, 48:50-57.
86. Stephan H., Frahm H., Baron M. New and revised data on the volumes of brain structures in insectivores and primates. Folia Primatologica 1981, 35:1-29.
87. Stetler C., Miller G.E. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosomatic Medicine 2011, 73:114-126.
88. Strakowski S.M., Wilson D.R., Tohen M., Woods B.T., Douglass A.W., Stoll A.L. Structural brain abnormalities in first-episode mania. Biological Psychiatry 1993, 33:602-609.
89. Strakowski S.M., Adler C.M., DelBello M.P. Volumetric MRI studies of mood disorders: do they distinguish unipolar and bipolar disorder?. Bipolar Disorders 2002, 4:80-88.
90. Strakowski S.M., DelBello M.P., Adler C.M. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Molecular Psychiatry 2005, 10:105-116.
91. Sublette M.E., Oquendo M.A., Mann J.J. Rational approaches to the neurobiologic study of youth at risk for bipolar disorder and suicide. Bipolar Disorders 2006, 8:526-542.
92. Sullivan E.V., Lane B., Deshmukh A., Rosenbloom M.J., Desmond J.E., Lim K.O., Pfefferbaum A. In vivo mammillary body volume deficits in amnesic and nonamnesic alcoholics. Alcoholism, Clinical and Experimental Research 1999, 23:1629-1636.
93. Swaab, D.F., 2003. Hypothalamic involvement in psychiatric disorders. In: Aminoff, M.J., Boller, F., Swaab, D.F. (Series Eds.), Handbook of clinical neurology, vol. 80. The human hypothalamus: Basic and clinical aspects. Elsevier, Amsterdam, pp. 248-272.
94. Swaab D.F., Fliers E. A sexually dimorphic nucleus in the human brain. Science 1985, 228:1112-1115.
95. Swaab D.F., Hofman M.A. An enlarged suprachiasmatic nucleus in homosexual men. Brain Research 1990, 537:141-148.
96. Swaab D.F., Fliers E., Partiman T.S. The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Research 1985, 342:37-44.
97. Takahashi T., Walterfang M., Wood S.J., Kempton M.J., Jogia J., Lorenzetti V., Soulsby B., Suzuki M., Velakoulis D., Pantelis C., Fangou S. Pituitary volume in patients with bipolar disorder and their first-degree relatives. Journal of Affective Disorders 2010, 124:256-261.
98. Tata D.A., Anderson B.J. The effects of chronic glucocorticoid exposure on dendritic length, synapse numbers and glial volume in animal models: implications for hippocampal volume reductions in depression. Physiology & Behavior 2010, 99:186-193.
99. Wellcome Trust Centre for Neuroimaging SPM5 http://www.fil.ion.ucl.ac.uk/spm/software/spm5/.
100. Wiegell M.R., Tuch D.S., Larsson H.B., Wedeen V.J. Automatic segmentation of thalamic nuclei from diffusion tensor magnetic resonance imaging. NeuroImage 2003, 19:391-401.
101. Zhou J.N., Riemersma R.F., Unmehopa U.A., Hoogendijk W.J., van Heerikhuize J.J., Hofman M.A., Swaab D.F. Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression. Archives of General Psychiatry 2001, 58:655-662.